Raily Aesthetic Medicine International Holdings (HKSE:02135) Moat Score: 0/10 (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02135 Raily Aesthetic Medicine International Holdings Ltd HKSE:02135
47 GF Score
Price HK$0.12
GF Value HK$0.14
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Raily Aesthetic Medicine International Holdings Moat Score?

Raily Aesthetic Medicine International Holdings has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Raily Aesthetic Medicine International Holdings has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Raily Aesthetic Medicine International Holdings might have No Moat - No discernible moat.

Raily Aesthetic Medicine International Holdings  (HKSE:02135) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Raily Aesthetic Medicine International Holdings Moat Score Related Terms

HKSE:02135
47GF Score
Raily Aesthetic Medicine International Holdings Ltd HKSE:02135
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Raily Aesthetic Medicine International Holdings (HKSE:02135) Overvalued in 2026?

Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings stock appears to be undervalued. The current stock price of HK$0.12 is trading 15% below its estimated GF Value™ of HK$0.14. GuruFocus considers Raily Aesthetic Medicine International Holdings to be Modestly Undervalued.

Key valuation signals for HKSE:02135:

  • Moat Score: 0
  • GF Value™: HK$0.14 vs. price of HK$0.12 (15% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02135 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raily Aesthetic Medicine International Holdings Business Description

Address No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN
Raily Aesthetic Medicine International Holdings Ltd is an investment holding company. The company were principally engaged in the provision of aesthetic medical services, sale of aesthetic medical equipment products and provision of consulting services. The group is organized into three reportable operating segments namely Aesthetic medical services comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology service and others; Aesthetic medical equipment products comprise principally sales of collagen injection products, surgical implants and aesthetic medical skincare products; Consulting services comprise principally management consulting services of which majority of revenue comes from Aesthetic medical services.
47GF Score

Get the complete analysis for HKSE:02135

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.12
Price
HK$0.14
GF Value